Becaplermin gel (PDGF-BB) as topical wound therapy. Plastic Surgery Educational Foundation DATA Committee.

Abstract	Becaplermin gel is the first topical growth factor to demonstrate therapeutic efficacy in the healing of diabetic wounds. For diabetic patients who have poorly healing ulcers despite good perfusion and a reasonable trial of wound care, this product may be of considerable benefit. It should be tried for a 2-week time period and the results objectively assessed before continuation of therapy.
Authors	D Ladin
Journal	Plastic and reconstructive surgery (Plast Reconstr Surg) Vol. 105 Issue 3 Pg. 1230-1 (Mar 2000) ISSN: 0032-1052 [Print] United States
PMID	10724287 (Publication Type: Journal Article)
Chemical References	Gels Platelet-Derived Growth Factor Proto-Oncogene Proteins c-sis Recombinant Proteins Becaplermin
Topics	Administration, Topical Becaplermin Diabetic Foot (drug therapy) Gels Humans Platelet-Derived Growth Factor (administration & dosage) Proto-Oncogene Proteins c-sis Recombinant Proteins (administration & dosage) Wound Healing

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!